603566.SH
普莱柯
SSE · Healthcare · Biotechnology · CN
CNY 10.22
−0.68%Margins
Gross margin
58.7%
EBITDA margin
31.0%
EBIT margin
17.9%
Net margin
16.3%
FCF margin
18.9%
6.5%
Return on equity
5.4%
Return on assets
7.1%
Return on invested capital
0.33x
Asset turnover
CNY 272.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026